Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3. [electronic resource]
Producer: 20050628Description: 2609-17 p. digitalISSN:- 1533-4406
- Adult
- Analysis of Variance
- Antiviral Agents -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Polyethylene Glycols
- RNA, Viral -- blood
- Recombinant Proteins
- Recurrence
- Ribavirin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.